Cargando…
Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats
Allopurinol (ALP) attenuates oxidative stress and diabetic cardiomyopathy (DCM), but the mechanism is unclear. Activation of nuclear factor erythroid 2‐related factor 2 (Nrf2) following the disassociation with its repressor Keap1 under oxidative stress can maintain inner redox homeostasis and attenu...
Autores principales: | Luo, Jierong, Yan, Dan, Li, Sisi, Liu, Shiming, Zeng, Fei, Cheung, Chi Wai, Liu, Hong, Irwin, Michael G., Huang, Huansen, Xia, Zhengyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991641/ https://www.ncbi.nlm.nih.gov/pubmed/31856386 http://dx.doi.org/10.1111/jcmm.14870 |
Ejemplares similares
-
Allopurinol ameliorates liver injury in type 1 diabetic rats through activating Nrf2
por: Zeng, Fei, et al.
Publicado: (2021) -
N-Acetylcysteine and Allopurinol Synergistically Enhance Cardiac Adiponectin Content and Reduce Myocardial Reperfusion Injury in Diabetic Rats
por: Wang, Tingting, et al.
Publicado: (2011) -
N-Acetylcysteine and Allopurinol Confer Synergy in Attenuating Myocardial Ischemia Injury via Restoring HIF-1α/HO-1 Signaling in Diabetic Rats
por: Mao, Xiaowen, et al.
Publicado: (2013) -
Up‐regulation of FoxO1 contributes to adverse vascular remodelling in type 1 diabetic rats
por: Liu, Jingjin, et al.
Publicado: (2020) -
FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes
por: Yan, Dan, et al.
Publicado: (2020)